Capricor Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$5.68-$23.40
Market Cap
$324.1M
Shares Short
12M

Financials

See more
Revenue (12 Mos)
$13.3M
Revenue Growth (YoY)
-7.9%
Gross Profit (12 Mos)
-$53.9M
Diluted EPS
-$1.73

News

See more

Yahoo Finance • 3 days ago

Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting

Yahoo Finance • 4 days ago

Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Yahoo Finance • 11 days ago

CAPRICOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Yahoo Finance • 12 days ago

Shareholders of Capricor Therapeutics, Inc. Should Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights – CAPR

About

CEO
Dr. Linda Marbán Ph.D.
CFO
Mr. Anthony J. Bergmann M.B.A.
Address
10865 Road to the Cure, San Diego, CA, United States, 92121
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
160